BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 11120923)

  • 41. Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method.
    Moschettini D; De Milito A; Catucci M; Marconi A; Rinina C; Bianchi-Bandinelli ML; Valensin PE
    Eur J Clin Microbiol Infect Dis; 1998 Feb; 17(2):117-9. PubMed ID: 9629978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human herpesvirus 7 primary infection in kidney transplant recipients.
    Antón A; Cervera C; Pumarola T; Moreno A; Benito N; Linares L; Esteva C; Cofán F; Jiménez de Anta MT; Marcos MA
    Transplantation; 2008 Jan; 85(2):298-302. PubMed ID: 18212637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
    Bounaadja L; Piret J; Goyette N; Boivin G
    J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
    Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
    Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
    J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus.
    Griffiths PD; Ait-Khaled M; Bearcroft CP; Clark DA; Quaglia A; Davies SE; Burroughs AK; Rolles K; Kidd IM; Knight SN; Noibi SM; Cope AV; Phillips AN; Emery VC
    J Med Virol; 1999 Dec; 59(4):496-501. PubMed ID: 10534732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human herpesvirus-6 and -7 after lung and heart-lung transplantation.
    Lehto JT; Halme M; Tukiainen P; Harjula A; Sipponen J; Lautenschlager I
    J Heart Lung Transplant; 2007 Jan; 26(1):41-7. PubMed ID: 17234516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. beta-Herpesvirus (human cytomegalovirus and human herpesvirus 6) reactivation in at-risk lung transplant recipients and in human immunodeficiency virus-infected patients.
    Michaelides A; Glare EM; Spelman DW; Wesselingh SL; Hoy JF; Mijch AM; Kotsimbos TC
    J Infect Dis; 2002 Jul; 186(2):173-80. PubMed ID: 12134252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human herpesvirus-7 in Brazilian liver transplant recipients: a follow-up comparison between molecular and immunological assays.
    Peigo MF; Thomasini RL; Puglia AL; Costa SC; Bonon SH; Boin IF; Leonardi M; Mota NG
    Transpl Infect Dis; 2009 Dec; 11(6):497-502. PubMed ID: 19671120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.
    Razonable RR; Brown RA; Humar A; Covington E; Alecock E; Paya CV;
    J Infect Dis; 2005 Oct; 192(8):1331-9. PubMed ID: 16170749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients.
    Humar A; Malkan G; Moussa G; Greig P; Levy G; Mazzulli T
    J Infect Dis; 2000 Apr; 181(4):1450-3. PubMed ID: 10762575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
    Wang FZ; Larsson K; Linde A; Ljungman P
    Bone Marrow Transplant; 2002 Oct; 30(8):521-6. PubMed ID: 12379892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation.
    Maeda Y; Teshima T; Yamada M; Shinagawa K; Nakao S; Ohno Y; Kojima K; Hara M; Nagafuji K; Hayashi S; Fukuda S; Sawada H; Matsue K; Takenaka K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Br J Haematol; 1999 Apr; 105(1):295-302. PubMed ID: 10233397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
    Grzywacz M; Deayton JR; Bowen EF; Wilson P; Emery VC; Johnson MA; Griffiths PD
    J Med Virol; 1999 Nov; 59(3):323-8. PubMed ID: 10502264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
    Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
    Br J Haematol; 2000 Dec; 111(3):774-81. PubMed ID: 11122137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.